Literature DB >> 20188851

The role of epigenetic events in genotoxic hepatocarcinogenesis induced by 2-acetylaminofluorene.

Igor P Pogribny1, Levan Muskhelishvili, Volodymyr P Tryndyak, Frederick A Beland.   

Abstract

It is well established that genotoxic reactivity of chemical carcinogens or their metabolites is a critical event in the initiation of tumorigenesis. However, the underlying mechanisms of events following initiation are less well understood, and with respect to genotoxic liver carcinogenesis, it is largely unknown how the initiated cells progress to form preneoplastic hepatic foci. In the present study, we investigated the underlying events associated with tumor-promoting activity of 2-acetylaminofluorene (2-AAF), a powerful complete genotoxic rat liver carcinogen. Male Sprague-Dawley rats were fed NIH-31 diet containing 0.02% of 2-AAF for 24 weeks, and the status of cytosine DNA methylation, histone methylation, and microRNA expression was determined in the livers of control and 2-AAF-fed rats. The results demonstrate that stages of multistage carcinogenesis following the initiation are driven primarily by carcinogen-induced epigenetic alterations. This was evidenced by altered global histone lysine methylation patterns, increased histone H3 lysine 9 and histone H3 lysine 27 trimethylation in the promoter regions of Rassf1a, p16(INK4a), Socs1, Cdh1, and Cx26 tumor suppressor genes, early Rassf1a and p16(INK4a) promoter CpG island hypermethylation, and altered microRNA expression in preneoplastic livers of rats exposed to 2-AAF. These changes were accompanied by dysregulation of the balance between cell proliferation and apoptosis, a fundamental pro-tumorigenic event in hepatocarcinogenesis. These results signify the fundamental role of epigenetic alterations in genotoxic liver carcinogenesis. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20188851     DOI: 10.1016/j.mrgentox.2010.02.011

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  Neuroendocrine aging precedes perimenopause and is regulated by DNA methylation.

Authors:  Eliza R Bacon; Aarti Mishra; Yiwei Wang; Maunil K Desai; Fei Yin; Roberta Diaz Brinton
Journal:  Neurobiol Aging       Date:  2018-10-05       Impact factor: 4.673

2.  Epigenetic events determine tissue-specific toxicity of inhalational exposure to the genotoxic chemical 1,3-butadiene in male C57BL/6J mice.

Authors:  Grace Chappell; Tetyana Kobets; Bridget O'Brien; Natalia Tretyakova; Dewakar Sangaraju; Oksana Kosyk; Kenneth G Sexton; Wanda Bodnar; Igor P Pogribny; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2014-09-18       Impact factor: 4.849

Review 3.  Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

Authors:  Xuejiao Tian; Saiyang Zhang; Hong-Min Liu; Yan-Bing Zhang; Christopher A Blair; Dan Mercola; Paolo Sassone-Corsi; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

4.  Enrichment of progenitor cells by 2-acetylaminofluorene accelerates liver carcinogenesis induced by diethylnitrosamine in vivo.

Authors:  María Paulette Castro-Gil; Ricardo Sánchez-Rodríguez; Julia Esperanza Torres-Mena; Carlos David López-Torres; Valeria Quintanar-Jurado; Nayeli Belem Gabiño-López; Saúl Villa-Treviño; Luis Del-Pozo-Jauner; Jaime Arellanes-Robledo; Julio Isael Pérez-Carreón
Journal:  Mol Carcinog       Date:  2021-03-25       Impact factor: 4.784

5.  Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma.

Authors:  Diego F Calvisi; Matthias Evert; Frank Dombrowski
Journal:  Mol Biol Int       Date:  2012-04-02

6.  Epigenetic factors in cancer risk: effect of chemical carcinogens on global DNA methylation pattern in human TK6 cells.

Authors:  Ali M Tabish; Katrien Poels; Peter Hoet; Lode Godderis
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

7.  Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review).

Authors:  Youhong Dong; Anping Wang
Journal:  Oncol Lett       Date:  2014-07-01       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.